Related references
Note: Only part of the references are listed.Comparison of an Aspergillus Real-time Polymerase Chain Reaction Assay with Galactomannan Testing of Bronchoalvelolar Lavage Fluid for the Diagnosis of Invasive Pulmonary Aspergillosis in Lung Transplant Recipients
Me-Linh Luong et al.
CLINICAL INFECTIOUS DISEASES (2011)
Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma
N. L. Smith et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
The Initial 96 Hours of Invasive Pulmonary Aspergillosis: Histopathology, Comparative Kinetics of Galactomannan and (1→3)-β-D-Glucan, and Consequences of Delayed Antifungal Therapy
William W. Hope et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001-2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database
Dimitrios P. Kontoyiannis et al.
CLINICAL INFECTIOUS DISEASES (2010)
In vitro susceptibility testing in Aspergillus species: an update
Cornelia Lass-Floerl
FUTURE MICROBIOLOGY (2010)
Strain-Dependent Variation in 18S Ribosomal DNA Copy Numbers in Aspergillus fumigatus
M. L. Herrera et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Molecular Identification of Aspergillus Species Collected for the Transplant-Associated Infection Surveillance Network
S. Arunmozhi Balajee et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Diagnostic imaging of experimental invasive pulmonary aspergillosis
Thomas J. Walsh et al.
MEDICAL MYCOLOGY (2009)
Performance Characteristics of the Platelia Aspergillus Enzyme Immunoassay for Detection of Aspergillus Galactomannan Antigen in Bronchoalveolar Lavage Fluid
S. Husain et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Ben De Pauw et al.
CLINICAL INFECTIOUS DISEASES (2008)
Galactomannan antigenemia in pediatric oncology patients with invasive aspergillosis
Randall Hayden et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2008)
Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients
Cornelius J. Clancy et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis
Andrea Francesconi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Laboratory diagnosis of invasive aspergillosis
WW Hope et al.
LANCET INFECTIOUS DISEASES (2005)
Efficacy and safety of generic amphotericin B in experimental pulmonary aspergillosis
V Petraitis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Efficacy, safety, and plasma pharmacokinetics of escalating dosages of intravenously administered ravuconazole lysine phosphoester for treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits
R Petraitiene et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Aspergillus terreus - An emerging amphotericin B-resistant opportunistic mold in patients with Hematologic malignancies
RY Hachem et al.
CANCER (2004)
Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: Variables that affect performance
KA Marr et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Infections due to Aspergillus terreus:: A multicenter retrospective analysis of 83 cases
WJ Steinbach et al.
CLINICAL INFECTIOUS DISEASES (2004)
Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid
B Musher et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction
TJ Walsh et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Experimental pulmonary aspergillosis due to Aspergillus terreus:: Pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B
TJ Walsh et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Efficacy of high-efficiency particulate air filtration in preventing aspergillosis in immunocompromised patients with hematologic malignancies
T Hahn et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2002)
Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: Correlation with galactomannan antigenemia
R Petraitiene et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)